Skip to main content

AS/Spondyloarthritis

      RT @swethaann23: Findings:
      1. 21% of the patients in the Ankylosing Spondylitis Registry of Ireland (ASRI) were unemploy
      3 years 5 months ago
      Findings: 1. 21% of the patients in the Ankylosing Spondylitis Registry of Ireland (ASRI) were unemployed which is higher than their national average. 2. Stong predictors of unemployment were - Male sex and worse disease activity outcome measures(BASMI and ASQoL) #ACR21 @RheumNow
      RT @swethaann23: #ACR21 @RheumNow
      Abst#0359 by Garrido-Cumbrera et al. has mapped out the journey from symptom onset to
      3 years 5 months ago
      #ACR21 @RheumNow Abst#0359 by Garrido-Cumbrera et al. has mapped out the journey from symptom onset to diagnosis of axSpA across 13 European countries.
      RT @swethaann23: #ACR21 @RheumNow
      Abst#0364 by Wetterslev et al. sought to identify axSpA characteristics of patients t
      3 years 5 months ago
      #ACR21 @RheumNow Abst#0364 by Wetterslev et al. sought to identify axSpA characteristics of patients tapered off TNFI and showed clinical and radiographic improvement. 🔽52% were tapered off ⭐️The highest predictor of success is a low physician global VAS score
      RT @doctorRBC: ⭐️AxSpA pts with decrease in oral microbial diversity
      ⭐️Immune response to oral/fecal microbes al
      3 years 5 months ago
      ⭐️AxSpA pts with decrease in oral microbial diversity ⭐️Immune response to oral/fecal microbes altered in AxSpA pts. ⭐️HLA-B27 associated ⬆️IgA coated microbes, may contribute to development of AxSpA Abs#0052 https://t.co/NQgm0lpYJj #ACR21 @RheumNow
      RT @_Castillo_Pedro: Year 2 f/u on PsA, axSpA, or RA using CT-P13, an infliximab (IFX) biosimilar. Pts either naive to I
      3 years 5 months ago
      Year 2 f/u on PsA, axSpA, or RA using CT-P13, an infliximab (IFX) biosimilar. Pts either naive to IFX or switched from IFX: 💠IFX-naive: improved disease activity 💠IFX-switched: maintained stable disease 💠No new safety concerns https://t.co/VGBicnq15w #ACR21 Abst#0817 @RheumNow
      Identifying Gaps in axSpA: Lessons from European Map of Axial Spondyloarthritis (EMAS)

      Dr. Sheila Reyes, ( @RHEUMaramp
      3 years 5 months ago
      Identifying Gaps in axSpA: Lessons from European Map of Axial Spondyloarthritis (EMAS) Dr. Sheila Reyes, ( @RHEUMarampa) discusses the three interesting abstracts were presented by the group of Prof. Marco Garrido-Cumbrera on the EMAS at #ACR21. https://t.co/Q50kEr5WEU https://t.co/5DScK5krtw
      AxSpA: Geographic Prevalence Association with HLA-B27: Dr. Rachel Tate ( @uptoTate )

      Dr. Rachel Tate discusses abstract
      3 years 5 months ago
      AxSpA: Geographic Prevalence Association with HLA-B27: Dr. Rachel Tate ( @uptoTate ) Dr. Rachel Tate discusses abstract #0368 presented at the #ACR21 annual meeting. https://t.co/CnIjlWuKjZ https://t.co/vytIdK9CCo
      Psoriatic arthritis (PsA) commonly affects peripheral joints. In up to a quarter of PsA patients, the spine may be involved and this is known as psoriatic spondylitis (PsSpA). An important research…
      RT @ACEJointHealth: Lianne Gensler presenting "Exercise Strategies for Ankylosing Spondylitis". Not all physical activit
      3 years 5 months ago
      Lianne Gensler presenting "Exercise Strategies for Ankylosing Spondylitis". Not all physical activity is similarly beneficial. Learn more now by attending her session at #ACR21! @CherylKoehn @ArthritisNetwrk @EIM_Canada @exerciseworks @PhysioKTBroker @jwhittak_physio @JasminKMa https://t.co/rER3EdCohO
      MRI Imaging in RA and SpA: Dr. Sheila Reyes ( @RHEUMarampa)

      Dr. Sheila Reyes discusses abstracts #0468 and #0469, prese
      3 years 5 months ago
      MRI Imaging in RA and SpA: Dr. Sheila Reyes ( @RHEUMarampa) Dr. Sheila Reyes discusses abstracts #0468 and #0469, presented at the #ACR21 annual meeting. https://t.co/MeVia60BNa https://t.co/WRgCifpioQ
      ×